Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
Top Cited Papers
- 14 June 2013
- journal article
- research article
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 1 (5), 369-376
- https://doi.org/10.1016/s2213-2600(13)70105-x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Obstructive Sleep Apnea Is Common in Idiopathic Pulmonary FibrosisChest, 2009
- Proton-Pump Inhibitor Use and the Risk for Community-Acquired PneumoniaAnnals of Internal Medicine, 2008
- Acute Exacerbations of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Sole Treatment of Acid Gastroesophageal Reflux in Idiopathic Pulmonary FibrosisChest, 2006
- Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2006
- High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2006
- The Clinical Course of Patients with Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 2005
- Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Analyses of Efficacy End Points in a Controlled Trial of Interferon-γ1b for Idiopathic Pulmonary FibrosisChest, 2005